Insights

Innovative Cancer Focus Stemcentrx specializes in developing therapies targeting cancer stem cells, which are critical in tumor initiation and recurrence. This positions the company as a valuable partner for organizations seeking cutting-edge oncology treatments and viral vector or antibody-based therapeutic collaborations.

Recent Acquisition Impact Since its acquisition by AbbVie in 2016 for 5.8 billion dollars, Stemcentrx has gained significant backing and resources, presenting opportunities to offer supplemental research tools, manufacturing capacities, or licensing collaborations aligned with their ongoing development pipeline.

Research and Manufacturing Capabilities With state-of-the-art laboratories and GMP manufacturing facilities in South San Francisco, Stemcentrx is equipped to collaborate on custom research, clinical trial support, and manufacturing services for advanced biopharmaceutical products targeting cancer.

Pipeline Development Opportunities Stemcentrx’s focus on antibody drug conjugates and proprietary platforms signifies potential for partnerships in antibody engineering, target discovery complementary technologies, or therapeutic delivery systems, appealing to companies in biotech and tech-driven drug development.

Market Position and Growth Operating in a highly competitive landscape with industry giants, Stemcentrx’s specialized focus and recent strategic acquisitions present opportunities for joint ventures, licensing deals, or co-development projects aimed at expanding their oncology pipeline and enhancing market share.

Stemcentrx, Inc. Tech Stack

Stemcentrx, Inc. uses 1 technology products and services including Apache, and more. Explore Stemcentrx, Inc.'s tech stack below.

  • Apache
    Web Servers

Stemcentrx, Inc.'s Email Address Formats

Stemcentrx, Inc. uses at least 1 format(s):
Stemcentrx, Inc. Email FormatsExamplePercentage
First.Last@stemcentrx.comJohn.Doe@stemcentrx.com
99%
F.Last@stemcentrx.comJ.Doe@stemcentrx.com
1%

Frequently Asked Questions

Where is Stemcentrx, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s main headquarters is located at 450 East Jamie Court South San Francisco, California 94080 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Stemcentrx, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Stemcentrx, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Stemcentrx, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s official website is stemcentrx.com and has social profiles on LinkedInCrunchbase.

What is Stemcentrx, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Stemcentrx, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, Stemcentrx, Inc. has approximately 6 employees across 2 continents, including North AmericaEurope. Key team members include Owner: J. A.Manager Statistics: S. E.Project Manager: V. D.. Explore Stemcentrx, Inc.'s employee directory with LeadIQ.

What industry does Stemcentrx, Inc. belong to?

Minus sign iconPlus sign icon
Stemcentrx, Inc. operates in the Biotechnology Research industry.

What technology does Stemcentrx, Inc. use?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s tech stack includes Apache.

What is Stemcentrx, Inc.'s email format?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s email format typically follows the pattern of First.Last@stemcentrx.com. Find more Stemcentrx, Inc. email formats with LeadIQ.

When was Stemcentrx, Inc. founded?

Minus sign iconPlus sign icon
Stemcentrx, Inc. was founded in 2008.

Stemcentrx, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates.

Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and motivated team committed to this mission. We are recruiting people with world-class expertise in their practice, versatility, high energy and an entrepreneurial spirit. 

Our state-of-the-art laboratories and manufacturing facilities are located in South San Francisco, California. We have a driven, ambitious, focused, hard-working, apolitical, fun, and collaborative culture that is more typical of Silicon Valley startups than large pharmaceutical companies. Our employees are compensated with salary, benefits and stock options.

Section iconCompany Overview

Headquarters
450 East Jamie Court South San Francisco, California 94080 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
2-10

Section iconFunding & Financials

  • $10M$25M

    Stemcentrx, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Stemcentrx, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.